12:00 AM
Jul 24, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Atrisone dapsone topical gel: Completed Phase II trial enrollment

Atrix Laboratories Inc. (ATRX), Fort Collins, Colo.
Product: Atrisone dapsone topical gel
Business: Autoimmune/Inflammation
Therapeutic category: Immune modulation

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >